Business Description
Liaoning Chengda Biotechnology Co Ltd
ISIN : CNE100004ZP2
Share Class Description:
SHSE:688739: Class ACompare
Compare
Traded in other countries / regions
688739.China IPO Date
2021-10-28Description
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 283.72 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | 407.58 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 18.07 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.6 | |||||
| 3-Year EBITDA Growth Rate | -15.7 | |||||
| 3-Year EPS without NRI Growth Rate | -24.8 | |||||
| 3-Year FCF Growth Rate | -44.8 | |||||
| 3-Year Book Growth Rate | 28 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.17 | |||||
| 9-Day RSI | 58.11 | |||||
| 14-Day RSI | 55.51 | |||||
| 6-1 Month Momentum % | -17.58 | |||||
| 12-1 Month Momentum % | -17.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.19 | |||||
| Quick Ratio | 20.8 | |||||
| Cash Ratio | 17.11 | |||||
| Days Inventory | 555.47 | |||||
| Days Sales Outstanding | 234.74 | |||||
| Days Payable | 237.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.49 | |||||
| Dividend Payout Ratio | 0.81 | |||||
| Forward Dividend Yield % | 3.49 | |||||
| 5-Year Yield-on-Cost % | 3.45 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 3.51 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 83.34 | |||||
| Operating Margin % | 32 | |||||
| Net Margin % | 23.87 | |||||
| FCF Margin % | 6.22 | |||||
| ROE % | 4.35 | |||||
| ROA % | 4.17 | |||||
| ROIC % | 10.53 | |||||
| ROC (Joel Greenblatt) % | 16.78 | |||||
| ROCE % | 5.47 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.41 | |||||
| PE Ratio without NRI | 23.12 | |||||
| Shiller PE Ratio | 16.64 | |||||
| PS Ratio | 6.78 | |||||
| PB Ratio | 1.24 | |||||
| Price-to-Tangible-Book | 1.31 | |||||
| Price-to-Free-Cash-Flow | 109.5 | |||||
| Price-to-Operating-Cash-Flow | 19.87 | |||||
| EV-to-EBIT | 11.94 | |||||
| EV-to-EBITDA | 11.94 | |||||
| EV-to-Revenue | 3.63 | |||||
| EV-to-FCF | 58.34 | |||||
| Price-to-Projected-FCF | 1.05 | |||||
| Price-to-Graham-Number | 1.16 | |||||
| Price-to-Net-Current-Asset-Value | 1.76 | |||||
| Price-to-Net-Cash | 2.32 | |||||
| Earnings Yield (Greenblatt) % | 8.38 | |||||
| FCF Yield % | 0.92 | |||||
| Forward Rate of Return (Yacktman) % | -4.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Liaoning Chengda Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,761.289 | ||
| EPS (TTM) (Â¥) | 1.01 | ||
| Beta | 0 | ||
| Volatility % | 18.41 | ||
| 14-Day RSI | 55.51 | ||
| 14-Day ATR (Â¥) | 0.508203 | ||
| 20-Day SMA (Â¥) | 27.9875 | ||
| 12-1 Month Momentum % | -17.28 | ||
| 52-Week Range (Â¥) | 24.61 - 35.71 | ||
| Shares Outstanding (Mil) | 416.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Liaoning Chengda Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Liaoning Chengda Biotechnology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Liaoning Chengda Biotechnology Co Ltd Frequently Asked Questions
What is Liaoning Chengda Biotechnology Co Ltd(SHSE:688739)'s stock price today?
The current price of SHSE:688739 is ¥28.69. The 52 week high of SHSE:688739 is ¥35.71 and 52 week low is ¥24.61.
When is next earnings date of Liaoning Chengda Biotechnology Co Ltd(SHSE:688739)?
The next earnings date of Liaoning Chengda Biotechnology Co Ltd(SHSE:688739) is .
Does Liaoning Chengda Biotechnology Co Ltd(SHSE:688739) pay dividends? If so, how much?
The Dividend Yield %  of Liaoning Chengda Biotechnology Co Ltd(SHSE:688739) is 3.49% (As of Today), Highest Dividend Payout Ratio of Liaoning Chengda Biotechnology Co Ltd(SHSE:688739) was 1.01. The lowest was 0.63. And the median was 0.82. The  Forward Dividend Yield % of Liaoning Chengda Biotechnology Co Ltd(SHSE:688739) is 3.49%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers